In vitro increase in intracellular calcium concentrations induced by low or high extracellular glucose levels in ependymocytes and serotonergic neurons of the rat lower brainstem.
D000496:Alloxan / Q000494:pharmacology; D000818:Animals; D001933:Brain Stem / Q000737:chemistry* / Q000166:cytology / Q000201:enzymology; D002118:Calcium / Q000032:analysis*; D002121:Calcium Channel Blockers / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004805:Ependyma / Q000737:chemistry*; D005941:Glucokinase / Q000032:analysis / Q000037:antagonists & inhibitors; D005947:Glucose / Q000008:administration & dosage / Q000032:analysis*; D007026:Hypothalamic Area, Lateral / Q000737:chemistry; D008297:Male; D009474:Neurons / Q000737:chemistry*; D009543:Nifedipine / Q000494:pharmacology; D011903:Raphe Nuclei / Q000737:chemistry; D051381:Rats; D017208:Rats, Wistar; D012701:Serotonin / Q000032:analysis / Q000502:physiology*; D014697:Ventromedial Hypothalamic Nucleus / Q000737:chemistry
D002121:Calcium Channel Blockers; D004791:Enzyme Inhibitors; D012701:Serotonin; D000496:Alloxan; D005941:Glucokinase; D009543:Nifedipine; D005947:Glucose; D002118:Calcium